Simultaneous determination of multiple cytokines reveals a pro-inflammatory and pro-angiogenic signature after major cardiothoracic surgery: Potential role of C-reactive protein

Cytokine

Volumn 60, Issue 3, 2012, Pages 593-595

  Tisato, Veronica ^a   Monasta, Lorenzo ^b   Biolo, Gianni ^c   Donatelli, Francesco ^d   Secchiero, Paola ^a   Zauli, Giorgio ^b  

^a UNIVERSITY OF FERRARA   (Italy)

^b INSTITUTE FOR MATERNAL AND CHILD HEALTH IRCCS BURLO GAROFOLO   (Italy)

^c UNIVERSITY OF TRIESTE   (Italy)

^d OSPEDALI RIUNITI   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; CHEMOKINE; CYTOKINE; INTERLEUKIN 6; INTERLEUKIN 8; MONOCYTE CHEMOTACTIC PROTEIN 1; RANTES; VASCULOTROPIN;

ANGIOGENESIS; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; C REACTIVE PROTEIN BLOOD LEVEL; CARDIOVASCULAR RISK; CORONARY ARTERY BYPASS SURGERY; CORONARY ARTERY DISEASE; CYTOKINE RELEASE; HIGH RISK PATIENT; LETTER; MORTALITY; NONHUMAN; POSTOPERATIVE INFLAMMATION; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; PROTEIN BLOOD LEVEL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; THORAX SURGERY; VEIN GRAFT DISEASE;

C-REACTIVE PROTEIN; CORONARY ARTERY BYPASS; CYTOKINES; HUMANS; INFLAMMATION; MACROPHAGES; NEOVASCULARIZATION, PHYSIOLOGIC; RISK FACTORS;

EID: 84867999359     PISSN: 10434666     EISSN: 10960023     Source Type: Journal    
DOI: 10.1016/j.cyto.2012.08.017     Document Type: Letter

References (12)

1. Ridker P.M. Role of inflammatory biomarkers in prediction of coronary heart disease. Lancet 2001, 358:946-948.
2. Reynolds G.D., Vance R.P. C-reactive protein immunohistochemical localization in normal and atherosclerotic human aortas. Arch. Pathol. Lab. Med. 1987, 111:265-269.
3. Liuzzo G., Biasucci L.M., Gallimore J.R., Grillo R.L., Rebuzzi A.G., Pepys M.B., et al. The prognostic value of C-reactive protein and serum amyloid a protein in severe unstable angina. N. Engl. J. Med. 1994, 331:417-424.
4. Haverkate F., Thompson S.G., Pyke S.D., Gallimore J.R., Pepys M.B. Production of C-reactive protein and risk of coronary events in stable and unstable angina, European concerted action on thrombosis and disabilities angina pectoris study group. Lancet 1997, 349:462-466.
5. Donatelli F., Corbella D., Di Nicola M., Carli F., Lorini L., Fumagalli R., et al. Preoperative insulin resistance and the impact of feeding on postoperative protein balance. A stable isotope study. J. Clin. Endocrinol. Metab. 2011, 96:E1789-1797.
6. Zauli G., Corallini F., Bossi F., Fischietti F., Durigotto P., Celeghini C., et al. Osteoprotegerin increases leukocyte adhesion to endothelial cells both in vitro and in vivo. Blood 2007, 110:536-543.
7. Sarjeant J.M., Rabinovitch M. Understanding and treating vein graft atherosclerosis. Cardiovasc. Pathol. 2002, 11:263-271.
8. Campioni D., Secchiero P., Corallini F., Melloni E., Capitani S., Lanza F., et al. Evidence for a role of TNF-related apoptosis-inducing ligand (TRAIL) in the anemia of myelodysplastic syndromes. Am. J. Pathol. 2005, 166:557-563.
9. Secchiero P., Zerbinati C., di Iasio M.G., Melloni E., Tiribelli M., Grill V., et al. Synergistic cytotoxic activity of recombinant TRAIL plus the non-genotoxic activator of the p53 pathway nutlin-3 in acute myeloid leukemia cells. Curr. Drug. Metab. 2007, 8:395-403.
10. Siervo M., Ruggiero D., Sorice R., Nutile T., Aversano M., Stephan B.C., et al. Angiogenesis and biomarkers of cardiovascular risk in adults with metabolic syndrome. J. Intern. Med. 2010, 268:338-347.
11. Suffee N., Richard B., Hlawaty H., Oudar O., Charnaux N., Sutton A. Angiogenic properties of the chemokine RANTES/CCL5. Biochem. Soc. Trans. 2011, 39:1649-1653.
12. Bhardwaj S., Roy H., Babu M., Shibuya M., Yla-Herttuala S. Adventitial gene transfer of VEGFR-2 specific VEGF-E chimera induces MCP-1 expression in vascular smooth muscle cells and enhances neointimal formation. Atherosclerosis 2011, 219:84-91.